Literature DB >> 10964655

Trafficking of human ADAM 12-L: retention in the trans-Golgi network.

S Hougaard1, F Loechel, X Xu, R Tajima, R Albrechtsen, U M Wewer.   

Abstract

We have investigated the trafficking of the membrane-anchored form of human ADAM 12 (ADAM 12-L) fused to a green fluorescence protein tag. Subcellular localization of the protein in transiently transfected cells was determined by fluorescence microscopy and trypsin sensitivity. Full-length ADAM 12-L was retained in a perinuclear compartment, which was shown to be the trans-Golgi network. In contrast, ADAM 12-L lacking the cytoplasmic domain reached the cell surface. Based on analysis of deletions and mutations of the cytoplasmic tail of ADAM 12-L, the retention signal is comprised of both the cytoplasmic and transmembrane domains, but not the Src homology 3 domain (SH3) binding sites. These results raise the possibility that a trafficking checkpoint in the trans-Golgi network is one of the cellular mechanisms for regulation of ADAM 12-L function, by allowing a rapid release of ADAM 12-L to the cell surface under specific stimuli. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964655     DOI: 10.1006/bbrc.2000.3295

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.

Authors:  Yi Cao; Zhefeng Zhao; Joanna Gruszczynska-Biegala; Anna Zolkiewska
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

2.  ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.

Authors:  Camilla Fröhlich; Camilla Nehammer; Reidar Albrechtsen; Pauliina Kronqvist; Marie Kveiborg; Atsuko Sehara-Fujisawa; Arthur M Mercurio; Ulla M Wewer
Journal:  Mol Cancer Res       Date:  2011-08-29       Impact factor: 5.852

3.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

4.  RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.

Authors:  Katia Bourd-Boittin; Hélène Le Pabic; Dominique Bonnier; Annie L'Helgoualc'h; Nathalie Théret
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

Review 5.  ADAM 33 and its association with airway remodeling and hyperresponsiveness in asthma.

Authors:  Stephen T Holgate; Donna E Davies; Steuart Rorke; Julie Cakebread; Gillian Murphy; Robert M Powell; John W Holloway
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

Review 6.  The role of ADAM33 in the pathogenesis of asthma.

Authors:  Julie A Cakebread; H-M Haitchi; John W Holloway; Robert M Powell; Tim Keith; Donna E Davies; Stephen T Holgate
Journal:  Springer Semin Immunopathol       Date:  2003-11-15

7.  Ectodomain cleavage of the EGF ligands HB-EGF, neuregulin1-beta, and TGF-alpha is specifically triggered by different stimuli and involves different PKC isoenzymes.

Authors:  Andreas Herrlich; Eva Klinman; Jonathan Fu; Cameron Sadegh; Harvey Lodish
Journal:  FASEB J       Date:  2008-08-29       Impact factor: 5.191

8.  An arginine stretch limits ADAM10 exit from the endoplasmic reticulum.

Authors:  Elena Marcello; Fabrizio Gardoni; Monica Di Luca; Isabel Pérez-Otaño
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

9.  Identification of ILK as a new partner of the ADAM12 disintegrin and metalloprotease in cell adhesion and survival.

Authors:  Anthony Leyme; Katia Bourd-Boittin; Dominique Bonnier; Anaïs Falconer; Yannick Arlot-Bonnemains; Nathalie Théret
Journal:  Mol Biol Cell       Date:  2012-07-05       Impact factor: 4.138

10.  Podosomes and Invadopodia: Related structures with Common Protein Components that May Promote Breast Cancer Cellular Invasion.

Authors:  Daniel C Flynn; Youngjin Cho; Deanne Vincent; Jess M Cunnick
Journal:  Breast Cancer (Auckl)       Date:  2008-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.